Sasha Main

www.linkedin.com

Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy | npj Breast Cancer

Simulating cell-free chromatin using preclinical cancer models for liquid biopsy applications - ScienceDirect

Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer | Clinical Cancer Research | American Association for Cancer Research

Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay | Nature Communications

The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative - ScienceDirect

Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery

Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer

Google scholar